JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
  会員専用ページ

トップページ
学会案内
沿革
定款
役員・委員会
名誉会員・評議員
学術集会
総会学術集会
歴代総会・学術集会
支部・学術集会
学会教育研修会
国際関連学会
認定制度
リウマチ専門医
リウマチ指導医
教育施設
学会出版物
学会誌MR
NLリウマチ
リウマチ学用語集
会員手続き
本サイトについて
よくある質問
関連リンク集
サイトマップ
プライバシー
CASE REPORT

A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer

Authors

Yohei Kida1,2, Etsuko Maeshima1, Kanako Furukawa1, Tomohiro Ichikawa1, Mikako Goda1 and Masakazu Ichinose1

  1. Third Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan
  2. Present address: Department of Inernal Medicine, Kainan City Hospital, 272-3 Hikata, Kainan 642-0002, Japan
Received:

28 July 2006

Accepted:

27 February 2007

Full Text

> Download (PDF) (member's only)

Abstract

A 53-year-old man was diagnosed with polymyositis (PM) in 1997 and treated with prednisolone. The subjective symptoms of pneumonitis were poor. However, the KL-6 values were elevated to 2230IU/l in March 2001. Abdominal computer tomography findings revealed a pancreatic-tail tumor and multiple liver nodules, diagnosed as primary pancreatic adenocarcinoma with multiple liver metastasis. The stage of the pancreatic cancer was IV, and curative surgery of the tumor was not indicated. Chemotherapy and radiotherapy were administered for the liver metastasis. However, these therapies were ineffective against the tumors. The patient died on 12 September 2001. If a high level of KL-6 is found without the increasing activity of lung disease containing interstitial pneumonia in PM patients, examination for the internal malignancies including pancreatic cancer should be performed, although cases of PM with a significantly high level of KL-6 associated with pancreatic cancer are rare.

Key words

KL-6 - Pancreatic cancer - Polymyositis


Copyright Japan College of Rheumatology All rights reserved.